AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Alumis Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG01J7X4PP0
6.78▼ 0.04 (-0.59%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
6.82
Day's Range
6.48 – 6.83
52-Week Range
4.37 – 31.35
Volume
1.2M
Avg Volume
2.5M
Share Statistics
Shares Outstanding
Employees
224
Exchange
XNAS
Listed
2024-06-28
Share count as of August 6, 2026

Alumis Inc. Common Stock (ALMS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Alumis Inc. Common Stock (ALMS)
What is Alumis Inc. Common Stock's Market Cap?
Alumis Inc. Common Stock's Market Cap is $877.6M, based on as-reported figures from SEC (XBRL) filings.
What is Alumis Inc. Common Stock's Enterprise Value?
Alumis Inc. Common Stock's Enterprise Value is $813.9M, based on as-reported figures from SEC (XBRL) filings.
What is Alumis Inc. Common Stock's Price / Sales?
Alumis Inc. Common Stock's Price / Sales is 118.6×, based on as-reported figures from SEC (XBRL) filings.
What is Alumis Inc. Common Stock's EV / Revenue?
Alumis Inc. Common Stock's EV / Revenue is 110.0×, based on as-reported figures from SEC (XBRL) filings.
What is Alumis Inc. Common Stock's EV / EBITDA?
Alumis Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Alumis Inc. Common Stock's Revenue (TTM)?
Alumis Inc. Common Stock's Revenue (TTM) is $7.4M, based on as-reported figures from SEC (XBRL) filings.
What is Alumis Inc. Common Stock's Net Income (TTM)?
Alumis Inc. Common Stock's Net Income (TTM) is -$439.0M, based on as-reported figures from SEC (XBRL) filings.
What is Alumis Inc. Common Stock's EBITDA?
Alumis Inc. Common Stock's EBITDA is -$455.5M, based on as-reported figures from SEC (XBRL) filings.
What is Alumis Inc. Common Stock's Diluted EPS (TTM)?
Alumis Inc. Common Stock's Diluted EPS (TTM) is -3.39, based on as-reported figures from SEC (XBRL) filings.
What is Alumis Inc. Common Stock's EBITDA Margin?
Alumis Inc. Common Stock's EBITDA Margin is -6156.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ALMSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023
Revenue:
Total revenue
YoY growth-90.4%——
Operating expenses:
Research and development expenses, including related party expenses of $399, $259, $465 and $521 for the three and six months ended June 30, 2026 and 2025, respectively
General and administrative expenses
Intangible assets impairment loss——
Total operating expenses
% of revenue9056.4%5099.7%5680.4%
Loss from operations
% of revenue-8956.4%-4999.7%-5580.4%
Other income (expense):
Gain on bargain purchase—
Interest income
Other income (expenses), net
Total other income (expense), net
Net income (loss) before income taxes
Net income (loss)
% of revenue-8557.2%-4817.6%-5360.7%
Net income (loss) per share attributable to common stockholders, basic
Net income (loss) per share attributable to common stockholders, diluted